A physiotherapist by training, Karel joined Pfizer in 1987 and had the opportunity to work on numerous assignments in the Sales and Marketing Division.
In 2001, Karel decided to change his career trajectory and to join Pfizer Canada to lead the Neuroscience Marketing teams (launch Lyrica). It was in 2006 that Karel got the opportunity to work on the International scene and became European Brand Team Leader for a couple of key assets of Pfizer’s ‘Pain’ portfolio (Celebrex and later Lyrica). He relocated back to Europe and was based in Germany (Karlsruhe) and later Walton Oaks.
It was in 2008, as a result of Pfizer’s reorganization into Business Units, that Karel took upon the VP Marketing role for Europe and Canada in the Primary Care BU.
Beginning 2012, he took upon the Country Manager position for Belgium & Luxembourg, first as BU head for Oncology, later as GIP lead and recently as IM lead.
He is a member of the Pharma.be board, the LAWG and the Health, Science & Technology Group.
Karel holds a Master’s Degree in Physiotherapy of the Leuven University in Belgium.
He is married for almost 30 years to Marijke and has four children, three boys and one daughter.